Rewind Therapeutics
Antwerp
About Rewind Therapeutics
Rewind Therapeutics is a developer of novel therapeutics intended to facilitate the treatment for neurological diseases.The company's first-in-class remyelinating therapeutics block inhibitory signals that prevent the expansion and migration of oligodendrocyte stem cells in order to promote effective remyelination, enabling medical practitioners to treat patients suffering from multiple sclerosis and other myelin-related diseases with efficacy.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: Less than $1M
- Total funding: $21.6M
- Funding stage: Early Stage Venture
- Last round: Series A (Jan 2023)
- Website: rwdtx.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/rewind-therapeutics-41020 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.